EUVIMED · CrossrefZeitschrift
Artificial Intelligence in the Life Sciences
ISSN 2667-3185 · Elsevier BV
Neueste Artikel
A reproducible nine-step protocol for fine-tuning large language models on heterogeneous bioinformatics knowledge sources
ISAAC: Prior-aligned structural sensitivity auditing for drug–target interaction models
Single-cell morphological profiling reveals insights into programmed cell death
Artificial intelligence in drug discovery: Integrating data, models, and mechanisms for next-generation therapeutics
Transformer architectures for de novo peptide sequencing and peptide property prediction in LC–MS/MS proteomics
Protein overlap inflates apparent generalization in aptamer-protein interaction benchmarks
Reasoning, not deciding: A practitioner’s perspective on bounded agentic AI for real-time GMP bioreactor monitoring
Designing an LLM-based evaluation system for agentic AI in drug discovery through human alignment
Foundation models for science – an important topic for applied artificial intelligence
A distribution-aware and functionally relevant novel framework for generation and discovery of bioactive peptides
Evaluating the ultimate impact of artificial intelligence on drug discovery
From generative protein models to experimental proteins: Validation and benchmarking for deep generative protein design
Can phenotypic activity be predicted without experimental readouts?
Artificial intelligence for protein engineering: From prediction and generation to evidence-centred design cycles
Implementing XAI in life sciences: Key challenges and pathways to solutions
Protein family membership governs exosite predictability across the structural proteome
Can we reliably identify drug targets at the proteome scale using AlphaFold based docking or generative AI?
Evaluation beyond goodness of fit: Quantifying biophysical alignment of AI models for kinase-centric drug discovery
EmbryoTempoFormer: clip-based developmental tempo inference from zebrafish brightfield time-lapse microscopy
From Research to Impact: A Comprehensive Platform for AI Model Deployment in Drug Discovery
Artificial intelligence agents for the life sciences and drug discovery
Fine-tuning protein language models enhances the identification and interpretation of the transcription factors
SignalPath-Finder: Identifying TOR complex downstream target genes via pseudo-peak ranking and autoencoder-based optimization
Joint synthesis planning by leveraging common intermediates
MMI-DDI: multimodal mutual influence framework for drug-drug interaction prediction under drug cold start
Editorial Board
Temporal distribution shift in real-world pharmaceutical data: Implications for uncertainty quantification in QSAR models
Co-folding, the future of docking – prediction of allosteric and orthosteric ligands
Unraveling the co-morbidity between COVID-19 and neurodegenerative diseases through multi-scale graph analysis: A systematic investigation of biological databases and text mining
Hallucinations in medical devices
EUVIMED